[
    "{\"step_by_step_thinking\": \"Based on the information provided in the documents, avelumab has shown promising results in the treatment of bladder cancer. Document [1] mentions that the JAVELIN Bladder 100 trial established the role of avelumab as maintenance therapy for metastatic urothelial cancer, leading to its approval by the US FDA. Document [3] also states that avelumab was approved by the FDA for the maintenance treatment of locally advanced or metastatic urothelial carcinoma. Additionally, document [7] highlights the positive results of the JAVELIN Bladder 100 study, where avelumab maintenance treatment significantly improved overall survival in patients with advanced urothelial cancer. Therefore, based on this information, the answer is A. yes, avelumab is effective for bladder cancer.\", \"answer_choice\": \"A\"}"
]